RELATION OF THE LATE ACTIVATION ZONE WITH THE LEFT VENTRICLE MYOCARIDUM CHANGES IN CANDIDATES FOR RESYNCHRONIZING THERAPY

Aim. By non-invasive methods, to assess relations of the zone of late electrical activation with changes in the left ventricle (LV) myocardium structure in patients — candidates for cardiac resynchronizing therapy.

 Material and methods. Totally, 37 patients included, with III functional class of chronic heart failure (CHF). In all patients, there was complete His left bundle branch block (LBBB) with QRS width 205 (190; 215) ms. Non-invasive electrophysiological mapping (NEM) was done with the “Amycard01C EP LAB” (EP Solutions SA,Switzerland), and magnetic-resonance imaging (MRI). At the first step, multichannel electrocardiography (ECG) was done. At the second step, MRI was done (MAGNETOM Trio A Tim 3 T, Siemens AG,Germany) with intravenous contrast “Gadovist” load. Changes inLV myocardium structure (post-inflammatory fibrosis or scar tissue) were evaluated by segments, within the delayed MRI contrasting. At the third stage, individual models of ventricles were built up. Activation ofLV epicardium in LBBB was evaluated by NEM.

Results. Most oftenly the zone of late activation by NEM was found in the basal region on the border of posterior and lateral LV segments — 17 patients (46%) and in basal lateral LV segment — 8 (21%). By MRI, only post inflammatory fibrosis was found in 21 patient, among them in 5 the area of fibrosis was located on LV epicardium and overlapped the zone of late activation by NEM. Among 12 patients with ischemic heart disease 2 had scar onLV epicardium overlapping with the late activation zone. No one of 4 patients with combination of post-inflammatory fibrosis and ischemic scar did not show overlap of structural changes on the epicardium with the late activation zone.

Conclusion. Combination of NEM and MRI in pre-operational period of patients investigation make it to relate structural changes inLV myocardium with the zone of its late electrical activation. 

1. Jaffe LM, Morin DP. Cardiac resynchronization therapy: history, present status, and future directions. Ochsner J 2014; 14: 596–07.

2. Baldasseroni S, Gentile A, Gorini M, et al. Intraventricular conduction defects in patients with congestive heart failure: left but not right bundle branch block is an independent predictor of prognosis. A report from the Italian Network on Congestive Heart Failure (IN-CHF database). Ital. Heart J 2003; 4: 607–13.

3. Gorcsan J, Abraham T, Agler DA, et al. ASE Expert Consensus Statement: Echocardiography for Cardiac Resynchronization Therapy: Recommendations for Performance and Reporting – A Report from the American Society of Echocardiography Dyssynchrony Writing Group. Endorsed by the Heart Rhythm Society. J Am Soc Echocardiogr 2008; 21(3): 191–213.

4. Khan FZ, Virdee MS, Palmer CR, et al. Targeted left ventricular lead placement to guide cardiac resynchronization therapy: the TARGET study: a randomized, controlled trial. J Am Coll Cardiol 2012; 59: 1509–18.

5. Saba S, Marek J, Schwartzman D, et al. Echocardiography-guided left ventricular lead placement for cardiac resynchronization therapy: results of the Speckle Tracking Assisted Resynchronization Therapy for Electrode Region trial. Circ Heart Fail 2013; 6: 427–34.

6. Wagner A, Mahrholdt H, Holly TA, et al. Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study. Lancet 2003; 361: 374–79.

7. Revishvili ASh, Wissner E, Lebedev DS, et al. Validation of the mapping accuracy of a novel non-invasive epicardial and endocardial electrophysiology system. Europace 2015; 17: 1282–88.

8. Zubarev SV, Chmelevsky MP, Budanova MA, et al. Non-invasive electrophysiological mapping of the patients undergoing cardiac resynchronization therapy: the role of left ventricular lead position. Translyatsionnaya meditsina 2016; 3: 7–16. In Russian (Зубарев С.В., Чмелевский М.П., Буданова М.А. и др. Неинвазивное электрофизиологическое картирование и эффект от кардиоресинхронизирующей терапии: роль позиции левожелудочкового электрода. Трансляционная медицина 2016; 3: 7–16).

9. Cerqueira MD, Weissman NJ, Dilsizian V, et al. AHA Scientific Statement: Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 2002; 105: 539–42.

10. Berger T, Pfeifer B, Hanser FF, et al. Single-beat noninvasive imaging of ventricular endocardial and epicardial activation in patients undergoing CRT. PLoS One 2011; 6: 1–7.

11. Ploux S, Lumens J, Whinnett Z, et al. Noninvasive Electrocardiographic Mapping to Improve Patient Selection for Cardiac Resynchronization Therapy Beyond QRS Duration and Left Bundle Branch Block Morphology. J Am Coll Cardiol 2013; 61: 2435–43.

12. Sitnikova MYu, Bortsova MA, Galenko VL, et al. Continuum stages for prognosis improvement in different subgroups of heart failure patients: from the organization of management and optimization of physical rehabilitation program to specification of risk factors. Translyatsionnaya meditsina 2015; 2: 62–72. In Russian (Ситникова М.Ю., Борцова М.А., Галенко В.Л. и др. Этапы континуума для улучшения прогноза в разных подгруппах больных ХСН: от организации менеджмента и оптимизации программы физической реабилитации к уточнению доступных для исследования факторов риска. Трансляционная медицина 2015; 2: 62–72).

13. Doltra A, Stawowy P, Dietrich T, et al. Magnetic resonance imaging of cardiovascular fibrosis and inflammation: from clinical practice to animal studies and back. Biomed Res Int 2013: 1–10.

14. Mahrholdt H, Goedecke C, Wagner A, et al. Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology. Circulation 2004; 109: 1250–58.